Layoffs at Nkarta
- Layoff events
- 2
- verified and sourced
- Roles reported
- 71
- roles in total
- Announced between
- Oct 2023 to Mar 2025
- Reported by
- U.S. Securities and Exchange Commission, Nkarta, and Fierce Biotech
This page records what we could verify and source. It is not a complete record of every job cut at Nkarta: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| Nkarta |
Restructuring
Nkarta announced a reduction in force of 53 positions while focusing resources on its autoimmune NK-cell therapy programs. |
53 | Not known | Company-wide | ||
| Nkarta |
Restructuring
Nkarta announced 18 layoffs, about 10% of staff, while focusing resources on later-stage cell-therapy programs. |
18 | Not known | United States |
1 source for Nkarta |
Where this comes from
Every cut listed for Nkarta was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about Nkarta? Tell us on our Discord and we will check it.